Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

SGLT2 Inhibitors Tied to Uptick in Hemoglobin and Hematocrit

(MedPage Today) -- DENVER -- Treatment with SGLT2 inhibitors was linked with modest but statistically significant increases in hemoglobin and hematocrit levels across a broad spectrum of patient populations, according to a systematic review and...

SGLT2 Inhibitors Tied to Uptick in Hemoglobin and Hematocrit

We haven't written up this one. MedPage Today has the full story — the link below goes straight to it.

Read the original at medpagetoday.com →

More in Health & Medicine

More from Sunday 25 October →